Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
THEMIS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -28.74-22.7392.3735.77690.93

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -28.74 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77
Mar2020690.93

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77
-94.82
Mar2020 690.93 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹1,145.4 Cr 0.2% -7.4% -44.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,091.0 Cr 2.3% 3.2% 9.5% Stock Analytics
DIVIS LABORATORIES ₹181,302.0 Cr -0.2% 4.5% 49.6% Stock Analytics
CIPLA ₹119,038.0 Cr -0.2% -2% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹117,170.0 Cr 3.7% 6.5% 16.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,061.0 Cr -0% -4.6% -6.2% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

0.2%

-7.4%

-44.4%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses